Brands, Oncologists, Rheumatologist Oppose Part B Step Therapy, But Patient Group Gives Conditional Support

August 08, 2018
Brand drug makers and doctors who earn a big share of their revenue from administering drugs oppose CMS’ new Medicare Advantage step therapy policy, but Patients for Affordable Drugs President David Mitchell offered conditional, tepid support, and consumer group Public Citizen said the policy “needs scrutiny.” Mitchell and Public Citizen do not get money from the industries affected by the policy. Step therapy is a policy that lets plans require that enrollees try cheaper versions of drugs before moving to...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on the coming Democrat-controlled House of Representatives, drug pricing reforms, Medicaid policy, FDA news and much more.